MARTHA ROSTRAN: Open Payments
NPI 1083086722 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 19 payments from 9 companies in 2025. Trend: 2023 $1,514 · 2024 $908 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 6 | $416 |
| Vifor Pharma, Inc. | 4 | $398 |
| Fresenius USA Marketing, Inc. | 3 | $62 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
Products named: Veltassa, XPHOZAH 30 MG, VELPHORO, IBSRELA, ACTHAR, LUPKYNIS, JARDIANCE, FUROSCIX.
Industry payments across FL — which companies pay providers there.
